Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1998-4-27
|
| pubmed:abstractText |
A randomised, double-blind, placebo-controlled trial with lithium succinate ointment was conducted in patients with AIDS-associated facial seborrhoeic dermatitis. Twice daily applications of the ointment brought about a rapid (2.5 days) and highly significant (P = 0.007) improvement in the severity of the condition. Lithium succinate ointment is well tolerated and can be a useful treatment for seborrhoeic dermatitis in this group of patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0307-6938
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
216-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9536541-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:9536541-Dermatitis, Seborrheic,
pubmed-meshheading:9536541-Dermatologic Agents,
pubmed-meshheading:9536541-Double-Blind Method,
pubmed-meshheading:9536541-Facial Dermatoses,
pubmed-meshheading:9536541-Humans,
pubmed-meshheading:9536541-Lithium Compounds,
pubmed-meshheading:9536541-Male,
pubmed-meshheading:9536541-Ointments,
pubmed-meshheading:9536541-Treatment Outcome
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
|
| pubmed:affiliation |
Department of Dermatology, Westminster Hospital, London, UK.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|